Search Results - "Dionisio, Rossana"
-
1
Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients
Published in Journal of clinical oncology (01-08-2006)“…To investigate the activity of letrozole plus/minus oral metronomic cyclophosphamide as primary systemic treatment (PST) in elderly breast cancer patients. One…”
Get full text
Journal Article -
2
Down-Regulation of Phosphatidylinositol 3′-Kinase/AKT/Molecular Target of Rapamycin Metabolic Pathway by Primary Letrozole-Based Therapy in Human Breast Cancer
Published in Clinical cancer research (01-05-2008)“…Purpose: The phosphatidylinositol 3′-kinase (PI3K)/AKT/molecular target of rapamycin (mTOR) pathway is involved in the development of tumor resistance to…”
Get full text
Journal Article -
3
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications
Published in Critical reviews in oncology/hematology (01-05-2024)“…In recent years, cancer research has highlighted the role of disrupted microbiota in carcinogenesis and cancer recurrence. However, microbiota may also…”
Get full text
Journal Article -
4
Clinical value of offering multiple chemotherapy lines to a luminal-like metastatic breast cancer: A case report with eribulin
Published in Tumori (01-12-2023)“…Introduction: The achievement of complete response with chemotherapy after multiple treatment lines in metastatic breast cancer and the chemosensitivity in a…”
Get full text
Journal Article -
5
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer
Published in Clinical genitourinary cancer (01-10-2023)“…Poly ADP-ribose polymerase inhibitors (PARPis) have clinical activity in several cancers. The rationale of their therapeutic use in urothelial cancer (UC)…”
Get full text
Journal Article -
6
Frequency of Germline and Somatic IBRCA1/I and IBRCA2/I Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis
Published in Cancers (01-04-2023)“…Our updated systematic review and meta-analysis investigates the frequency of germline and somatic BRCA1 and BRCA2 mutations in patients with prostate cancer…”
Get full text
Journal Article -
7
Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey
Published in Tumori (01-06-2024)“…Purpose: Cancer treatment–induced bone loss is a side effect of hormonal therapy that can severely affect patients' quality of life. The aim of this survey was…”
Get full text
Journal Article -
8
Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis
Published in Cancers (24-04-2023)“…In prostate cancer (PC), the presence of somatic and/or germline mutation provides prognostic and predictive information. Meta-analysis aims to estimate the…”
Get full text
Journal Article -
9
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis
Published in Clinical genitourinary cancer (01-04-2024)“…Treatment of metastatic hormone-sensitive prostate cancer (mHSPC) dramatically changed. PEACE-1 and ARASENS trials established triplet therapy efficacy…”
Get full text
Journal Article